Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8221657rdf:typepubmed:Citationlld:pubmed
pubmed-article:8221657lifeskim:mentionsumls-concept:C0149925lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1704387lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1522642lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0300926lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:8221657lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:8221657pubmed:issue21lld:pubmed
pubmed-article:8221657pubmed:dateCreated1993-11-29lld:pubmed
pubmed-article:8221657pubmed:abstractTextGastrin, cholecystokinin (CCK), and CCK-related peptides comprise a hormonal family characterized by an identical carboxy-terminal amino acid sequence, a domain critical for receptor binding. The addition of gastrin to small cell lung cancer (SCLC) cells causes a rapid and transient increase in the intracellular concentration of calcium ([Ca2+]i). Furthermore, gastrin acts as a direct growth factor through CCKB/gastrin receptors. We report here that the expression of the mRNA coding for CCKB/gastrin receptors correlates with the responsiveness of SCLC cells to gastrin in terms of Ca2+ mobilization and stimulation of clonal growth in semisolid medium. The GLC19 SCLC cell line had no detectable expression of CCKB/gastrin receptor mRNA. Accordingly, gastrin (1-100 nM) did not cause any measurable increase in [Ca2+]i. In contrast, the addition of cholecystokinin residues 26-33 (CCK-8) caused a rapid and transient increase in [Ca2+]i in this cell line. CCK-8 mobilized Ca2+ in a dose-dependent manner in the nanomolar range (half-maximal stimulatory concentration = 12 nM). Furthermore, the selective CCKA antagonist CAM-1481 inhibited the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 3 nM) in GLC19 but not in H510 cells. The selective CCKB/gastrin antagonist blocked the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 80 pM) in H510 but not in GLC19 cells. Thus, the effects of CCK-8 are mediated through CCKA receptors in GLC19 cells and via CCKB/gastrin receptors in H510 cells. CCK-8 markedly stimulated colony formation in GLC19 cells in a dose-dependent manner in the nanomolar range, whereas over the same concentration range, gastrin had no effect on clonal growth. CAM-1481 inhibited the CCK-stimulated colony formation in GLC19 but not in H510 cells. Our results show, for the first time, that CCKA receptors can mediate Ca2+ mobilization and growth in SCLC cells and that SCLC cells express two distinct functional CCK receptor subtypes.lld:pubmed
pubmed-article:8221657pubmed:languageenglld:pubmed
pubmed-article:8221657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:citationSubsetIMlld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8221657pubmed:statusMEDLINElld:pubmed
pubmed-article:8221657pubmed:monthNovlld:pubmed
pubmed-article:8221657pubmed:issn0008-5472lld:pubmed
pubmed-article:8221657pubmed:authorpubmed-author:WalshJ HJHlld:pubmed
pubmed-article:8221657pubmed:authorpubmed-author:RozengurtEElld:pubmed
pubmed-article:8221657pubmed:authorpubmed-author:NeuIIlld:pubmed
pubmed-article:8221657pubmed:authorpubmed-author:SethiTTlld:pubmed
pubmed-article:8221657pubmed:authorpubmed-author:HergetTTlld:pubmed
pubmed-article:8221657pubmed:issnTypePrintlld:pubmed
pubmed-article:8221657pubmed:day1lld:pubmed
pubmed-article:8221657pubmed:volume53lld:pubmed
pubmed-article:8221657pubmed:ownerNLMlld:pubmed
pubmed-article:8221657pubmed:authorsCompleteYlld:pubmed
pubmed-article:8221657pubmed:pagination5208-13lld:pubmed
pubmed-article:8221657pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:meshHeadingpubmed-meshheading:8221657-...lld:pubmed
pubmed-article:8221657pubmed:year1993lld:pubmed
pubmed-article:8221657pubmed:articleTitleCCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.lld:pubmed
pubmed-article:8221657pubmed:affiliationImperial Cancer Research Fund, London, England.lld:pubmed
pubmed-article:8221657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8221657pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8221657lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8221657lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8221657lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8221657lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8221657lld:pubmed